Navigation Links
Cambrex Reports First Quarter 2009 Results
Date:5/5/2009

EAST RUTHERFORD, N.J., May 5 /PRNewswire-FirstCall/ -- Cambrex Corporation (NYSE: CBM) reports first quarter results for the period ended March 31, 2009.

Highlights

  • Sales increased 8.7% compared to first quarter 2008 excluding the impact of foreign currency. Reported sales declined by 2.8% for the quarter.
  • EBITDA was $13.0 million versus adjusted EBITDA of $13.5 million in the same quarter last year (see attached table).
  • Debt, net of cash was $95.3 million at the end of first quarter 2009, a $3.8 million improvement during the quarter excluding the impact of final payments to former executives, strategic alternative related payments and foreign currency on cash balances. On a reported basis, debt, net of cash increased $4.0 million.

Basis of Reporting

The Company has provided a reconciliation from adjusted and other non-GAAP amounts to GAAP amounts at the end of this press release. Management believes that this basis of reporting provides a more meaningful representation of the Company's operating results for the periods presented due to the magnitude and nature of certain recorded expenses.

First Quarter 2009 Operating Results

First quarter 2009 sales of $60.0 million were 2.8% lower than the first quarter 2008. Sales were unfavorably impacted 11.5% due to exchange rates reflecting a stronger U.S. dollar. Excluding the currency impact, sales increased 8.7%. The increase is primarily due to higher volumes of two active pharmaceutical ingredients ("APIs") manufactured under long term supply agreements, higher volumes of controlled substances and slightly higher custom development revenues, partially offset by lower sales of generic APIs.


'/>"/>

SOURCE Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Cambrex Receives Notice Regarding NYSE Listing
2. Cambrex Reports Third Quarter 2008 Results
3. Cambrex Appoints Steven M. Klosk as President and CEO
4. Cambrex to Announce Fourth Quarter and Full Year 2007 Financial Results on February 14, 2008
5. Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast
6. Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results
7. TorreyPines Therapeutics Reports First Quarter 2009 Financial Results
8. United Therapeutics Reports First Quarter 2009 Financial Results
9. Osteotech Reports First Quarter 2009 Financial Results
10. InterMune Reports First Quarter 2009 Financial Results and Business Highlights
11. Idenix Pharmaceuticals Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative ... study of its canine osteoarthritis stem cell product, currently under development for FDA ... and will be marketed in the US by Aratana. This product, termed AT-016, ...
(Date:7/30/2015)... , July 30, 2015  With over 60,000 customers across the globe, ISN improves ... 450 hiring organizations with more than 60,000 safe and reliable contractors in over 80 countries. ... ... Over ... Headquartered in Dallas, TX ...
(Date:7/30/2015)... , July 30, 2015  Discovery Laboratories, Inc. ... has received the second $1.0M tranche under a ... (SBIR) grant valued at up to $3.0 million ... KL4 surfactant as a potential medical countermeasure to ... Labs was awarded an initial $1.0 million under ...
(Date:7/29/2015)... PARIS , July 30, 2015 ... leader, reports results for the second quarter of ... the group,s results and its performance in different ... transcript:  http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire ... - Q2 results - Performance drivers ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... Novavax, Inc. (Nasdaq: NVAX ) today announced ... a press release to be issued after 8:00 a.m. local ... investor conference call at 10:00 a.m. The call will be ... Singhvi and other members of senior management. The dial-in number ...
... NEW YORK, March 23, 2011 ... ACCP ), a biopharmaceutical company leveraging its ... oncology, cancer supportive care and diabetes, has ... Care and Market Access.  A 16-year industry veteran, Mottola ...
... made of carbon nanotubes dipped in a polymer solution equal ... cells, a team of Case Western Reserve University engineers has ... to boost the power output and maintain the other advantages ... But already they,ve proved the simple technique can knock ...
Cached Biology Technology:Access Pharmaceuticals Appoints Industry Executive Anthony Mottola as Vice President of Managed Care and Market Access 2Access Pharmaceuticals Appoints Industry Executive Anthony Mottola as Vice President of Managed Care and Market Access 3Cheap catalyst made easy 2
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading ... for its second quarter ended June 30, 2015.  ... million, a decrease of 33% compared to $6.8 million in ... quarter of 2015 was $0.3 million, or $0.01 per diluted ... share, in the same period a year ago.  ...
(Date:7/21/2015)... July 21, 2015 Passwords have proven ... in the recent U.S. Office of Personnel Management ... the infosec conundrum, but developers and end-users are ... address this dilemma, Biometrics-as-a-Service provider HYPR Corp. announced ... SDK for third party integration. ...
(Date:7/9/2015)... Calif. , July 9, 2015  Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... Thursday, July 30, 2015 after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
... WASHINGTONA single, huge, violent storm that swept across the ... a new study shows. While storms have long ... study is the first to produce an actual body count. ... study,s authors say. This suggests that storms may play a ...
... world championship if we couldn,t distinguish the ball from its ... if your favourite team,s striker could see the movements of ... to flies. The minute brains of these aeronautic acrobats process ... the brain of the fly manages to perceive motion with ...
... 2010 Are online learning modules beneficial to educational ... learning modules to help increase participant understanding of key ... researchers found that participants both visited the sites on ... knowledge. Researchers at the University of Arizona, led ...
Cached Biology News:Staggering tree loss from 2005 Amazon storm 2Staggering tree loss from 2005 Amazon storm 3Staggering tree loss from 2005 Amazon storm 4The brain of the fly -- a high-speed computer 2The brain of the fly -- a high-speed computer 3The brain of the fly -- a high-speed computer 4Online learning supplements watershed program 2
Plasmid expressing Zeocin resistance gene....
...
Hygromycin resistance gene (hph), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
... FRT-PGK-gb2-neo-FRT template is designed to allow ... The FRT-PGK-gb2-neo-FRT template encodes the neomycin/kanamycin ... (gb2) for expression of kanamycin resistance in ... (PGK) for expression of neomycin resistance in ...
Biology Products: